References
- Noorgaard JP, van Gool JD, Hjalmas K, Djurhuus JC, Hellstrom A L. Standardization and definitions in lowerurinary tractdy sfunction in children. International Children's Continence Society. Br J Urol 1998;81(S uppl 3):S1-16
- Hellstrom A L, Hanson E, Hansson S, Hjalmas K, Jodal U. Micturition habits and incontinence in 7-year-old Swedish schoolentrants. Eur J Pediatr 1990;149:434-7 https://doi.org/10.1007/BF02009667
- Deluca F G, Swenson O, Fisher JH, Loutfi A H. The dysfunctional lazy bladdersyndrome in children. Arch Dis Child 1962;37:117-21 https://doi.org/10.1136/adc.37.192.117
- Bauer S B, Koff S A, Jayanthi V R. Voiding dysfunction in children: neurogenic and non-neurogenic. In: Walsh P C, Retik A B, Vaughn E D, Wein A J, editors. Campbell's Urology. 8th Ed. Philadelphia: W.B. Saunders Co, 2002:2231-83
- Sher P K, Reinberg Y. Successful treatment of giggle incontinence with methylphendiate. J Urol 1996;156:656-8 https://doi.org/10.1016/S0022-5347(01)65776-8
- Hoebeke P, Vande Walle J, Everaert K, Van Laecke E, Van Gool JD. Assessment of lowerurinary tract dysfunction in children with nonneuropathic bladder sphincter dysfunction. Eur Urol 1999;35:57-69 https://doi.org/10.1159/000019820
- Wehby M C et al. Occult tight filum terminale syndrome: results of surgicaluntethering. Pediatr Neurosurg 2004;40: 51-8 https://doi.org/10.1159/000078908
- Saedi N A, Schulman S L. Natural history of voiding dysfunction. Pediatr Nephrol 2003;18:894-7 https://doi.org/10.1007/s00467-003-1210-5
- van G ool JD, K uitjen R H, D onckerw olcke R A, M esser A P, Vijverberg M. B ladder-sphincter dysfunction, urinary infection and vesico-ureteral reflux with special reference to cog nitiv e bladder training. Contrib Nephrol 1984;39:190-210
- Smellie JM, Gruneberg R N, Bantock H M, Prescod N. Prophylactic co-trim oxazole and trimethoprim in the management of urinary tract infection in children. Pediatr Nephrol 1988;2:12-7 https://doi.org/10.1007/BF00870372
- Bauer S B. Special considerations of the overactiv e bladder in children. Urology 2002;60:43-9 https://doi.org/10.1016/S0090-4295(02)01793-4
- Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics 1997;100:228-32 https://doi.org/10.1542/peds.100.2.228
- Erickson B A, Austin JC, Cooper C S, Boyt M A. Polyethyleneglycol 3350 for constipation in children with dysfunctional elim ination. J Urol 2003;170:1518-20 https://doi.org/10.1097/01.ju.0000083730.70185.75
- Wiener JS, Scales M T, Hampton J, King L R, Surwit R, Edwards C L. Long-term efficacy of simple behavioral therapy for daytime wetting in children. J Urol 2000;164:786-90 https://doi.org/10.1016/S0022-5347(05)67313-2
- Goode P S. Behavioral and drug therapy for urinary incontinence. Urology 2004;63(3 S uppl 1):S58-64 https://doi.org/10.1016/j.urology.2003.10.032
- Hellstrom A L, Hjalmas K, Jodal U. Rehabilitation of the dysfunctional bladder in children: method and 3-year follow - up. J Urol 1987;138:847-9 https://doi.org/10.1016/S0022-5347(17)43395-7
- Wiener JS, Scales M T, Hampton J, K ing L R, Surwit R, Edwards C L. Long-term efficacy of simple behavioral therapy for daytime wetting in children. J Urol 2000;164:786-90 https://doi.org/10.1016/S0022-5347(05)67313-2
- Allen H A, Austin JC, Boyt M A, Hawtrey C E, Cooper C S. Initialtrial of timedvoidingis warranted for all children with day time incontinence. Urology 2007;69:962-5 https://doi.org/10.1016/j.urology.2007.01.049
- Appel R A. Oxybutynin. The clinicalex perience. Contemp Urol 1991;3:60-7
- Andersson K E. Antimuscarinics for treatment of overactive bladder. Lancet Neurol 2004;3:46-53 https://doi.org/10.1016/S1474-4422(03)00622-7
- Kim K M, Lee S W. Efficacy and Tolerability of Tolterodine Compared to Oxybutynin in Children with a Neurogenic Bladder. Korean J Urol 2005;46:598-603
- R aes A, H oebeke P, S eg aert I, V an L aecke E, D ehoorne J, Vande W alle J. R etrospectiv e analysis of efficacy and tolerability of tolterodine in children with overactiv e bladder. Eur Urol 2004;45:240-4 https://doi.org/10.1016/j.eururo.2003.10.009
- Ayan S, Kaya K, Topsakal K, Kilicarslan H, Gokce G, Gultekin Y. Efficacy of tolterodine as a first-line treatment for non-neurog enic voiding dy sfunction in children. BJU Int 2005;96:411-4 https://doi.org/10.1111/j.1464-410X.2005.05641.x
- Nijman R J, Borg stein N G, Ellsworth P, Djurhuus JC. Tolterodine treatment for children with symptoms of urinaryurge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebocontrolled trials. J Urol 2005; 173:1334-9 https://doi.org/10.1097/01.ju.0000152322.17542.63
- Austin P F, Homsy Y L, Masel JL, Cain M P, Casale A J, Rink R C. a-A drenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction. J Urol 1999;162:1064-7 https://doi.org/10.1016/S0022-5347(01)68067-4
- Cain M P, Wu S D, Austin P F, Herndon C D, Rink R C. Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol 2003;170:1514-7 https://doi.org/10.1097/01.ju.0000085961.27403.4a
- Kramer S A, Rathbun S R, Elkins D, Karnes R J, Husmann D A. Double-blind placebo controlled study of a-adrenergic receptorantag onists (dox azosin) for treatment of voiding dysfunction in the pediatric population. J Urol 2005;173: 2121-4 https://doi.org/10.1097/01.ju.0000157689.98314.69
- Fouron JC, Chicoine R. E C Gchanges in fatal imipram ine (T ofranil) intoxication. Pediatrics 1971;48:777-81
- Sureshkumar P, Bower W, Craig JC, Knight JF. Treatment of daytim Eurinary incontinence in children: a system atic review of randomized controlled trials. J Urol 2003;170:196-200 https://doi.org/10.1097/01.ju.0000072341.34333.43